ATE475667T1 - Templat-fixierte peptidomimetika - Google Patents

Templat-fixierte peptidomimetika

Info

Publication number
ATE475667T1
ATE475667T1 AT07701901T AT07701901T ATE475667T1 AT E475667 T1 ATE475667 T1 AT E475667T1 AT 07701901 T AT07701901 T AT 07701901T AT 07701901 T AT07701901 T AT 07701901T AT E475667 T1 ATE475667 T1 AT E475667T1
Authority
AT
Austria
Prior art keywords
tyr
template
dpro
cys
ala
Prior art date
Application number
AT07701901T
Other languages
English (en)
Inventor
Steven Demarco
Reshmi Mukherjee
Kerstin Moehle
John Robinson
Heiko Henze
Barbara Romagnoli
Daniel Obrecht
Frank Gombert
Christian Ludin
Jan Vrijbloed
Original Assignee
Polyphor Ltd
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor Ltd, Univ Zuerich filed Critical Polyphor Ltd
Application granted granted Critical
Publication of ATE475667T1 publication Critical patent/ATE475667T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Reversible Transmitting Devices (AREA)
AT07701901T 2007-02-28 2007-02-28 Templat-fixierte peptidomimetika ATE475667T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH2007/000101 WO2008104090A1 (en) 2007-02-28 2007-02-28 Template-fixed peptidomimetics

Publications (1)

Publication Number Publication Date
ATE475667T1 true ATE475667T1 (de) 2010-08-15

Family

ID=37891752

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07701901T ATE475667T1 (de) 2007-02-28 2007-02-28 Templat-fixierte peptidomimetika

Country Status (20)

Country Link
US (7) US8399611B2 (de)
EP (1) EP2132221B1 (de)
JP (1) JP5140686B2 (de)
KR (1) KR101479148B1 (de)
CN (1) CN101641372B (de)
AT (1) ATE475667T1 (de)
AU (1) AU2007348171B2 (de)
BR (1) BRPI0721259C1 (de)
CA (1) CA2679414C (de)
DE (1) DE602007008150D1 (de)
DK (1) DK2132221T3 (de)
EA (1) EA017583B1 (de)
ES (1) ES2349879T3 (de)
IL (1) IL200312A (de)
MX (1) MX2009008843A (de)
NO (1) NO342598B1 (de)
NZ (1) NZ579875A (de)
PL (1) PL2132221T3 (de)
PT (1) PT2132221E (de)
WO (1) WO2008104090A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007079597A1 (en) 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity
AU2007345497B2 (en) 2007-01-29 2013-01-17 Polyphor Ltd. Template-fixed peptidomimetics
AU2007348171B2 (en) 2007-02-28 2012-09-06 Polyphor Ltd. Template-fixed peptidomimetics
WO2010127704A1 (en) * 2009-05-07 2010-11-11 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
WO2011066869A1 (en) * 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics
US20150030561A1 (en) 2011-05-16 2015-01-29 Genzyme Corp. Use of CXCR4 Antagonists
SG195055A1 (en) * 2011-06-07 2013-12-30 Polyphor Ag Beta - hairpin peptidomimetics as cxc4 antagonists
WO2013050346A1 (en) * 2011-10-07 2013-04-11 Polyphor Ag Template -fixed peptidomimetics as inhibitors of fpr1
MX355396B (es) * 2012-06-06 2018-04-18 Polyphor Ag Peptido - mimeticos de la horquilla beta.
US9775877B2 (en) * 2012-08-08 2017-10-03 Polyphor Ag Combinations with a backbone-cyclized peptide
WO2019156137A1 (ja) 2018-02-08 2019-08-15 株式会社ステムリム 乾癬の治療薬
WO2020071520A1 (ja) * 2018-10-05 2020-04-09 株式会社ステムリム 間葉系幹細胞の動員活性を有するペプチド
US12304933B2 (en) 2018-10-05 2025-05-20 StemRIM Inc. Disease treatment drug based on mesenchymal-stem-cell mobilization
JP2023549921A (ja) 2020-11-19 2023-11-29 スペクシス アーゲー がんを治療するためのペプチドｃｘｃｒ４阻害剤およびタキサンを含む医薬組み合わせ
WO2022184320A2 (en) 2021-03-03 2022-09-09 Spexis Ag Medical use of cyclic peptides
WO2023285677A1 (en) 2021-07-16 2023-01-19 Spexis Ag Pharmaceutical combinations for treating cancer
WO2023285681A1 (en) 2021-07-16 2023-01-19 Spexis Ag Pharmaceutical combinations for treating cancer
WO2025068348A1 (en) 2023-09-27 2025-04-03 Spexis Ag Pharmaceutical combination of cxcr4 and pd-1 inhibitors for treating cancer
WO2025068346A1 (en) 2023-09-27 2025-04-03 Spexis Ag Pharmaceutical combination of cxcr4, pd-1 and fak inhibitors for treating cancer

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1367789B (zh) 1999-08-30 2012-06-06 波利弗尔股份公司 模板固定的β-发夹环模拟物的合成
BRPI0207502B1 (pt) * 2001-02-23 2018-10-09 Polyphor Ltd compostos, enanciômeros, composição farmacêutica, uso de compostos, e, processo para a fabricação de compostos
CN101157924A (zh) 2001-12-11 2008-04-09 人体基因组科学有限公司 嗜中性白细胞因子α
US20040009890A1 (en) * 2002-01-07 2004-01-15 Erickson John W. Broad spectrum inhibitors
EP1532164B1 (de) 2002-08-20 2012-09-26 Polyphor Ltd. Template-fixierte peptidmimetika mit antibakterieller wirkung
US7855179B2 (en) 2002-10-02 2010-12-21 Polyphor Ltd. Template-fixed peptidomimetics with antimicrobial activity
DE60321053D1 (de) 2003-05-02 2008-06-26 Polyphor Ag Matrizenfixierte peptidmimetika als medikamente gegen hiv und krebs
WO2004096839A1 (en) 2003-05-02 2004-11-11 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
US7681235B2 (en) 2003-05-19 2010-03-16 Radware Ltd. Dynamic network protection
CN100595277C (zh) 2003-11-15 2010-03-24 波利弗尔有限公司 模板固定的β发夹环模拟物及其在噬菌体展示中的用途
CA2598360C (en) 2005-02-17 2016-12-20 Universitat Zurich Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
EP1879911B1 (de) 2005-05-02 2011-08-17 Polyphor Ltd. Farbstoffkonjugate von schablonenfixierten peptidomimetika
WO2007079597A1 (en) 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity
AU2007345497B2 (en) 2007-01-29 2013-01-17 Polyphor Ltd. Template-fixed peptidomimetics
AU2007348171B2 (en) 2007-02-28 2012-09-06 Polyphor Ltd. Template-fixed peptidomimetics
WO2010015287A2 (en) 2008-08-08 2010-02-11 Polyphor Ag Template-fixed peptidomimetics
US8883720B2 (en) 2008-11-26 2014-11-11 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
WO2010127704A1 (en) 2009-05-07 2010-11-11 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
JP5727479B2 (ja) 2009-08-05 2015-06-03 ポリフォー・アクチェンゲゼルシャフトＰｏｌｙｐｈｏｒ Ａｇ コンホメーションを固定された、合成マクロ環化合物
WO2011060832A1 (en) 2009-11-20 2011-05-26 Polyphor Ag Template-fixed peptidomimetics with ccr10 antagonistic activity
WO2011066869A1 (en) 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics
CA2789030C (en) 2010-02-05 2020-07-21 Polyphor Ag Template - fixed peptidomimetics with cxcr7 modulating activity
WO2011095218A1 (en) 2010-02-05 2011-08-11 Polyphor Ag Template-fixed pep tidomime tics with cxcr7 modulating activity
US8895499B2 (en) 2010-08-05 2014-11-25 Polyphor Ag β-hairpin peptidomimetics
SG195055A1 (en) 2011-06-07 2013-12-30 Polyphor Ag Beta - hairpin peptidomimetics as cxc4 antagonists
WO2013050346A1 (en) 2011-10-07 2013-04-11 Polyphor Ag Template -fixed peptidomimetics as inhibitors of fpr1
WO2013139697A1 (en) 2012-03-17 2013-09-26 Polyphor Ag Conformationally constrained, fully synthetic macrocyclic compounds
MX355396B (es) 2012-06-06 2018-04-18 Polyphor Ag Peptido - mimeticos de la horquilla beta.
SG11201500130WA (en) 2012-08-08 2015-03-30 Polyphor Ag Combinations with a backbone-cyclized peptide
US9775877B2 (en) 2012-08-08 2017-10-03 Polyphor Ag Combinations with a backbone-cyclized peptide
CN105324390B (zh) 2013-03-30 2021-10-19 波利弗尔股份公司 β-发夹肽模拟物
KR102279427B1 (ko) 2013-03-30 2021-07-20 폴리포 리미티드 Beta-헤어핀 펩타이드 모방체
NZ722025A (en) 2013-12-27 2019-06-28 Polyphor Ag Beta-hairpin peptidomimetics as selective elastase inhibitors
EA034910B1 (ru) 2013-12-27 2020-04-06 Полифор Аг Бета-шпилечные пептидомиметики в качестве селективных ингибиторов эластазы

Also Published As

Publication number Publication date
WO2008104090A1 (en) 2008-09-04
US20200399317A1 (en) 2020-12-24
JP5140686B2 (ja) 2013-02-06
CA2679414C (en) 2014-10-28
US9556234B2 (en) 2017-01-31
US11421001B2 (en) 2022-08-23
PT2132221E (pt) 2010-10-26
NZ579875A (en) 2012-02-24
DK2132221T3 (da) 2010-11-22
US20130150299A1 (en) 2013-06-13
US8399611B2 (en) 2013-03-19
CN101641372A (zh) 2010-02-03
EP2132221A1 (de) 2009-12-16
BRPI0721259C1 (pt) 2021-05-25
US20150080317A1 (en) 2015-03-19
EP2132221B1 (de) 2010-07-28
US8921325B2 (en) 2014-12-30
NO342598B1 (no) 2018-06-18
US10787486B2 (en) 2020-09-29
MX2009008843A (es) 2009-08-28
US10144765B2 (en) 2018-12-04
AU2007348171B2 (en) 2012-09-06
JP2010519331A (ja) 2010-06-03
BRPI0721259A2 (pt) 2013-01-15
US20100048463A1 (en) 2010-02-25
US9879047B2 (en) 2018-01-30
DE602007008150D1 (de) 2010-09-09
PL2132221T3 (pl) 2011-04-29
AU2007348171A1 (en) 2008-09-04
CN101641372B (zh) 2012-11-28
EA200901178A1 (ru) 2010-04-30
NO20093064L (no) 2009-09-28
BRPI0721259B8 (pt) 2020-09-15
EA017583B1 (ru) 2013-01-30
HK1138011A1 (en) 2010-08-13
CA2679414A1 (en) 2008-09-04
BRPI0721259B1 (pt) 2020-04-07
KR101479148B1 (ko) 2015-01-05
US20190100558A1 (en) 2019-04-04
US20170096453A1 (en) 2017-04-06
KR20100014596A (ko) 2010-02-10
ES2349879T3 (es) 2011-01-12
IL200312A0 (en) 2010-04-29
US20180127467A1 (en) 2018-05-10
IL200312A (en) 2014-11-30

Similar Documents

Publication Publication Date Title
DK2132221T3 (da) Template-fikserede peptidomimetika
MY199965A (en) Bridged bicyclic inhibitors of menin-mll and methods of use
CL2008002097A1 (es) Compuestos derivados de heterociclos condensados sustituidos, inhibidores de cinasa de fosfatidil-inositol-3; composicion farmaceutica; y uso en el tratamiento del cancer.
TN2011000382A1 (en) Indole derivatives as crth2 receptor antagonists
CL2012000623A1 (es) Compuestos derivados de 4-[4,4-dimetil-5oxo-3-(piridin-ilmetil)-2-tioxoimidazolidin-1-il]-2-(trifluorometil)benzonitrilo, con propiedades antiandrogenicas; metodo de preparacion; composcion farmaceutica; y su uso para el tratamiento y/o profilaxis de cancer de prostata.
WO2010034032A3 (en) Methods for preparing purified polypeptide compositions
IN2012DN02730A (de)
IN2012DN00754A (de)
ATE458740T1 (de) 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
PH12019550241A1 (en) Mic-1 compounds and uses thereof
CL2011002300A1 (es) Compuestos derivados de 2,4-diamiropirimidinas 5-sustitudas inhibidoras de quinasa ptk2; preparaciones farmaceuticas; y su uso para el tratamiento y/o la prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes.
NZ603196A (en) Methods of use of soluble cd24 for therapy of rheumatoid arthritis
WO2011133815A3 (en) Composite scanning mirror systems
PH12016502242A1 (en) 1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
EP4545589A3 (de) Zusammensetzungen mit glucose und hemicellulose und ihre verwendung
MX2017009600A (es) Derivados de 2-fenil-3h-imidazo[4,5-b]piridina utiles como inhibidores de actividad de receptor huerfano similar a tirosina cinasa (ror1) de tirosina cinasa de mamifero.
AU2013208104A8 (en) Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof
AU2011279845A8 (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists
MX2024013184A (es) Metodos y composiciones para tratar apnea del sue?o
UY33153A (es) Formulación tópica oftálmica de péptidos
AU2017394032A8 (en) Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome
WO2008049098A3 (en) ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR α1
CL2008001322A1 (es) Compuestos derivados de triazolil-aminopirimidina, sustituida con heterociclos; composicion farmaceutica; y uso en el tratamiento del cancer.
MX387920B (es) Peptidos antagonistas de prgc.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2132221

Country of ref document: EP